RedHill Biopharma Ltd. ADR (RDHL)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
CEO:
Dror Ben-Asher
Employees:
210
21 HA'ARBA'A STREET, TEL AVIV, L3, 64739
972-3-541-3131
Date | Ratio |
---|---|
2023-03-23 | 1:40 |
RedHill Biopharma Ltd. primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain. Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|